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properties of nanogold including nanogold surface Plasmon absorption and nanogold surface Plas-
mon light scattering are illustrated. The physical, chemical, biosynthesis methods of nanogold prep-
aration are presented. Catalytic properties as well as biomedical applications are highlighted as one
of the most important applications of nanogold. Biosensing, and diagnostic and therapeutic appli-
cations of gold nanoparticles are evaluated. Moreover, gold nanoparticles in drugs, biomolecules
and proteins’ delivery are analyzed. Gold nanoparticles for the site-directed photothermal applica-
tions are reviewed as the most fruitful research area in the future.
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The term nano originates from the greek word ‘‘nanos’’ which
means dwarf or small. When nano is used as a preﬁx it means
one billionth part of (109). In nanotechnology, nano refers to
things in the range of 1–100 nanometers (abbreviated as nm) in
size. Atoms are less than one nm in size; molecules and cells
vary in size from one to several nanometers. One deﬁnition
of nanogold is that it concerns itself.
2. Properties of nanogold
2.1. The nanogold surface plasmon absorption
A strong absorption band in the visible region is shown with
gold nanoparticles when the frequency of the electromagnetic
ﬁeld is resonant with the coherent electron motion, which is
called surface plasmon resonance absorption (Ivan et al.,
2005). Interaction with the electric ﬁeld results in a polariza-
tion of the electrons with respect to and relative to the ionic
core of a nanoparticle (Fig. 1). The dipole oscillations of the
free electrons with respect to the ionic core of a spherical nano-
particle result in the so-called surface plasmon absorption
(Stephan and Mostafa, 2003). When the frequency of the elec-
tromagnetic ﬁeld becomes resonant with the coherent electron
motion, a strong absorption band around 520 nm in the spec-
trum is observed, which is the origin of the observed brilliant
color of the nanoparticles in solution (Gustav and Mie, 1908).
The peak intensity and position of the surface plasmon
absorption band are dependent on the size, the shape of nano-
particles and the dielectric constant of the metals as well as the
medium surrounding the particles (Stephen and Mostafa,
2000). As the size increases, the absorption maximum is red Field
Surface Charge
Time t Time t + T/2
scheme of surface plasmon absorption of spherical
s illustrating the excitation of the dipole surface
illation.shifted slightly. Link and El-Sayed (Stephen and Mostafa,
1999) have shown that the bandwidth decreases with the in-
crease of the nanoparticles’ size particularly when the nanopar-
ticles are lesser than 20 nm in diameter. On the other hand, the
bandwidth increases with the increase of the nanoparticles’ size
when the nanoparticles are larger than 420 nm. They also
found that the absorption coefﬁcient is linearly dependent on
the volume of the nanoparticles which is in agreement with
the Mie theory (Gustav and Mie, 1908).
2.2. The nanogold surface plasmon light scattering
Upon illumination by a white light beam, the gold particle sus-
pensions scatter colored light (Stephen and Mostafa, 2004).
The suspensions of light-scattering nanogold particles show
appearance similar to ﬂuorescent solutions (Yguerabide,
1998). The light scattering is sensitive to the size, the shape
and the composite of the nanoparticles. Nanoparticles of
58 nm diameter scatter green light while those of 78 nm diam-
eter scatter yellow light and gold nanorods scatter red light un-
der illumination of a beam of white light (So¨nnichsen et al.,
2002).3. Nanogold preparation methods
3.1. Physical methods
Laser ablation method is used to produce gold nanoparticles
by using the pulsed laser irradiation of gold target in water
in the absence of any additives, at (532 nm, 10 ns, 10 Hz), or
(266 nm) wavelengths (Ko et al., 2006). Inert gas condensation
can be used for the preparation of gold nanoparticles (Lee
et al., 2005). In this method, the gold nanoparticles as soon
as they are formed rapidly collide with inert gas in a low-pres-
sure environment and thus smaller and controlled nanoparti-
cles are formed. The advantage of these methods is the
narrow particle size distribution of the produced gold nano-
particles, while its limitation is the need for expensive equip-
ment. Other physical methods such as thermolysis of gold(I)
complex at 180 C for 5 h under nitrogen atmosphere
(Yamamoto and Nakamoto, 2003), radiolysis of gold salts in
aqueous solution using c-irradiation-induced reduction in the
ﬁeld of a 60Co c-ray source (Henglein and Meisel, 1998;
Dawson and Kamat, 2000), photochemistry, e.g. in the
HAuCl4 solution containing certain amounts of protective
agent and acetone, the colloidal gold particles with an average
Biopharmaceutical applications of nanogold 181diameter of 5 nm (r= 0.86) were prepared by UV 300 nm
irradiation (Mallick et al., 2001; Sau et al., 2001), and sono-
chemistry using ultrasound-induced reduction of gold salts in
aqueous solution (Chen et al., 2001; Pol et al., 2003; Reed
et al., 2003) have been used to prepare a variety of gold
nanoparticles.
3.2. Chemical methods
Emulsiﬁcation procedure produces gold nanoparticles but with
a wide distribution of particle diameters (Pal et al., 2007).
Nanogold particles are prepared by reduction of the gold ions
in the presence of a dispersant in order to avoid excessive gold
agglomeration. Frens, (1973) and Turkevitch et al. (1951) ini-
tially introduced a sodium citrate reduction of HAuCl4 for the
synthesis of stable gold nanoparticles. In addition there are
other reductants such as sodium borohydride (Wagner et al.,
2008), stannous chloride (Vasˇkelis et al., 2007) and ascorbic
acid (Sun et al., 2009). Amine-containing molecules for exam-
ple, branched poly(ethyleneimine) (PEI) Note et al., 2006,
third-generation poly(propyleneimine) dendrimer (PPI-G3) in
the presence of sunlight (Luo, 2008), azacryptand at room tem-
perature (Lee et al., 2007), amino acid (Selvakannan et al.,
2004), polysaccharide (Huang and Yang, 2004), gallic acid
(Wang et al., 2007), alcohols, chitosan (Shih et al., 2009) or
other organic compounds are also used as a reductant for
the synthesis of nanogold.
There are several reported modiﬁed chemical methods
including seed-mediated growth where small particles pro-
duced by other techniques like irradiation were exploited as
seeds and fresh Au(III) ions were reduced onto the surface
of the seed particles by reducing agents like ascorbic acid
(Brown and Natan, 1998; Jana et al., 2001), use of reverse mi-
celles which involves reduction of HAuCl4 in sodium bis (2-
ethylhexyl)sulfosuccinate/isooctane reverse micelles system
using reducing agents like ascorbic acid (Chiang, 2000), phase
transfer reactions as a representative reaction in a novel water–
cyclohexane two-phase system, the aqueous formaldehyde is
transferred to cyclohexane phase via reaction with dodecyl-
amine to form reductive intermediates in cyclohexane; the
intermediates are capable of reducing gold ions in aqueous
solution to form gold nanoparticles in cyclohexane solution
at room temperature. (Esumi et al., 2000; Haifeng et al.,
2005). In view of all these methods, it was reported that the
chemical methods are still the preferred method for the prepa-
ration of gold nanoparticles than other methods.
3.3. Biosynthesis methods
Biosynthesis of nanoparticles as an emerging highlight of the
intersection of nanotechnology and biotechnology has received
considered attention due to a growing need to develop environ-
mentally benign technologies in material syntheses. Sastry and
coworkers have reported the extracellular synthesis of gold
nanoparticles by fungus Fusarium oxysporum and actinomycete
Thermomonospora sp., respectively (Ahmad et al., 2003a,b). The
same group has reported the intracellular synthesis of gold
nanoparticles by fungus Verticillium sp. as well (Mukherjee
et al., 2001). The reaction of AuCl4 ions with the extract of
geranium leaves and an endophytic fungus, Colletotrichum sp.,
present in the leaves, leads to the formation of AuNPs (Shankaret al., 2003). Nair and Pradeep reported the growth of nanocrys-
tals and nanoalloys using Lactobacillus (Nair and Pradeep,
2002). Daizy has reported a successful attempt on the extract
of Volvariella volvacea, an edible mushroom, as reducing and
protecting agent for the synthesis of gold, silver and Au–Ag al-
loy nanoparticles. Gold nanoparticles of different sizes
(20–150 nm) and shapes, from triangular to nearly spherical
and hexagonal nanoprisms, are obtained by this novel method.
The size and shape of gold nanoparticles are also found to de-
pend on the temperature of the extract (Philip, 2009).
Gold nanoparticles of 20–100 nm diameter were synthesized
within HEK-293 (human embryonic kidney), HeLa (human
cervical cancer), SiHa (human cervical cancer), and SKNSH
(human neuroblastoma) cells. Incubation of 1 mM tetrachloro-
aurate solution, prepared in phosphate buffered saline (PBS),
pH 7.4, with human cells grown to 80% conﬂuency yielded
systematic growth of nanoparticles over a period of 96 h. The
cells, stained due to nanoparticle growth, were adherent to
the bottom of the wells of the tissue culture plates, with their
morphology preserved, indicating that the cell membrane was
intact. Transmission electron microscopy of ultrathin sections
showed the presence of nanoparticles within the cytoplasm
and in the nucleus, the latter being much smaller in dimension.
Scanning near ﬁeld microscopic images conﬁrmed the growth
of large particles within the cytoplasm. Normal cells gave
UV–visible signatures of higher intensity than the cancer cells.
Differences in the cellular metabolism of cancer and noncancer
cells were manifested, presumably in their ability to carry out
the reduction process. The differential ability with which nano-
particles are synthesized by cancer and normal cells can have
implications to cancer diagnostics (Anshup et al., 2005).4. Applications of nanogold
4.1. Catalytic properties
Few years ago, nanogold received wide interests due to the
availability of small sized nanoparticles which provide large
surface-to-volume ratio compared to the bulk materials and
thus became active for catalysis. Fig. 2 shows the publication
of gold catalysis since 1901 from Science ﬁnder Scholar and
Fig. 3 shows the patents on the gold catalysis in the past dec-
ades (Hutchings, 2004). Recent years have witnessed a tremen-
dous growth in the number of gold-catalyzed highly selective
chemical transformations (Arcadi and Di Giuseppe, 2004).
The catalysis of organic reactions by gold compounds has been
shown to be a powerful tool in organic synthesis (Thompson,
1999). Although gold was considered to be an inert metal for a
long time, its ability to behave as a soft Lewis acid has only
been recognized recently. Such a property allows gold to acti-
vate unsaturated functionalities such as alkynes, alkenes, and
allenes to create carbon–carbon and carbon–heteroatom
bonds under extremely mild conditions (Georgy et al., 2005;
Balme et al., 2003). Moreover, by pre-coordination gold may
activate sp, sp2, and sp3 carbon–hydrogen bonds efﬁciently.
This may provide new opportunities in organic chemistry using
gold as a catalyst. In 1986, the Ito–Hayashi asymmetric aldol
reaction catalyzed by homogeneous gold was successfully
reported for the ﬁrst time (Sawamura et al., 1995). Thereafter,
Fukuda and Utimoto, (1991) and Teles et al., (1998) as well as
the Hashmi group (Hashmi et al., 2000) and others (Hayashi
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182 F.K. Alanazi et al.et al., 1992) initiated an impressive growth of activities on
homogeneous gold catalysis. Reactions types are as follows.
4.1.1. Gold-catalyzed C–C bond formations
4.1.1.1. Addition of terminal alkyne to C‚X group. The strong
coordination of terminal alkyne to gold catalyst results in
gold-acetylides (Fig. 4) which is used for the alkynylation of
orthoalkynylaryl aldehydes (Yao and Li, 2006). In addition,
gold further catalyzes an intramolecular cyclization of the hy-
droxyl–alkyne intermediate, leading to 1-alkynyl-1H-iso-
chromenes directly (Scheme 1). Such isochromenes are
common structural units in natural products and exhibit inter-esting biological activities such as antibiotic properties (Wang
et al., 1998). Au(III) and Au(I) catalyzes efﬁciently the direct
coupling of aldehyde, alkyne, and a secondary amine (A3-cou-
pling) (Fig. 5) Wei and Li, 2003a.
CHO
H
O
+
OH
5mol% Me3PAuCl
20mol% i-Pr2NEt
70 C water-toluene
81% Yield
Scheme 1
Au(I) R' Au H R' Auor
R' H
A
R CHO
N
H
+
N
R
N
R
R'
+H2O
B
Figure 5 Catalyzes efﬁciently the direct coupling of aldehyde, alkyne, and a secondary amine (A3-coupling).
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(Scheme 2) using 1 mol% of NaAuCl4-catalyzed three-compo-
nent reactions of aldehydes, amines, and alkynes followed by
cycloisomerization reaction under solvent-free conditions or in
H2O at 60 C was successfully reported by Yan and Liu
(2007). Kidwai et al. Mazaahir et al. (2007) reported an efﬁcient
and recyclable Au-nanoparticle, particle size 18 ± 2 nm, cata-
lyst for theA3-coupling reaction of aldehyde, amine, and alkyne
via C–H activation (Scheme 3). In 2005, Wei and Li, (2005b) re-
ported a gold-catalyzed direct addition of alkynes to an active
acyliminium ion, which was generated in situ from an imine
and an acidchloride, to afford propargylamides (Scheme 4).The reaction was efﬁciently catalyzed with 3 mol% of AuBr3
in the presence of i-Pr2NEt base in acetonitrile.
4.1.1.2. Addition of aryl group to terminal alkyne (hydroaryla-
tion). (Reetz et al., (2003) reported the direct addition of are-
nes to triple bonds with different gold catalysts; for example,
1,3,5-trimethylbenzene added to the internal alkyne carbon
in the presence of AuCl3/AgSbF6 (Eq. 1, Scheme 5). Both
the regio- and stereo-selectivities of hydroarylation have been
completely reversed with different electron-deﬁcient terminal
alkynes; the use of ethyl propiolate in the presence of
Ph3PAuCl/BF3.OEt gave exclusive (Z)-selectivity (Eq. 2,
NCHO
H+ R1
H
N
R2
1mol% NaAuCl4 H2O
60 C neat or in H2O N
NR1R2
28-98% Yield
N
NR1R2
*
Au
Scheme 2
CHO
H+ R1
H
N
R2
10 mol% Au nanoparticles
(18 ± 2 nm)
75-80 ºC, MeCN, N2
NR1R2
67-96 % Yield
Scheme 3
CH
H+ R2 Cl
3 mol% AuBr3, i-Pr2NEt
(18 ± 2 nm)
25 ºC, CH3CN
N
51-95 % Yield
O
N
R1 R1
R2
O
Scheme 4
184 F.K. Alanazi et al.Scheme 5) whereas in the case of 3-butyne-2-one (E)-selectivity
was observed (Eq. 3, Scheme 5).
4.1.1.3. Addition of aryl group to alkenes (hydroarylation).
NaAuCl4 has been used as a catalyst for the addition of in-
dole/pyrrole derivatives to a,b-unsaturated ketones or 1,3-
dicarbonyls (scheme 6) (Arcadi et al., 2004; Maria et al.,
2006). The gold catalyst makes electrophilic attach at the in-
dole forming indolyl-gold species A, which subsequently adds
to the a,b-unsaturated ketones resulting in the s-alkyl-gold
species B. Protonation of B produced the ﬁnal addition prod-
uct and regenerates the catalyst (Itahara et al., 1984). A tenta-
tive mechanism for this addition is illustrated in Scheme 7.
Regioselective direct electrophilic attack of the gold catalyst at
4.1.1.4. Addition of aryl group to imine. In Gold-catalyzed imi-
no Friedel–Crafts-type reaction the electron-rich arenes add
readily to imines in the presence of 5 mol% of AuOTf as a cat-alyst (Luo and Li, 2004) (Eq. 1, Scheme 8). Various amino acid
derivatives were prepared under the same conditions in high
yield (Eq. 2, Scheme 8).
4.1.1.5. Addition of aryl group to epoxide. Several publications
reported a cyclization of electron-rich arenes with tethered epox-
ides catalyzedbygold(III) (Eq. 1, Scheme9).Trimethoxybenzene
explored SN2-type addition at the less hindered primary carbon
of propylene oxide (Eq. 2, Scheme 9) (Shi and He, 2004a).
4.1.1.6. Intramolecular nucleophilic substitution of primary
alcohol mesylate (SN2 reaction). Scheme 10 shows the synthe-
sis of Chroman and benzopyranone derivatives by this method
(Scheme 10). The reaction mechanism involves arylgold(III) as
a reaction intermediate rather than a delocalized carbocation
in a typical Friedel–Crafts-type reaction. The arylgold interme-
diate then reacts with the sulfonate ester to give the ﬁnal prod-
uct (Shi and He, 2004b).
H+
1.5 mol% AuCl3
3 mol% AgSbF6
50 ºC, CH3NO2
86 % Yield
H COOEt+
1 mol% Ph3PAuCl
5 mol% BF3, Et2O
50 ºC, CH3NO2
90 % Yield
COOEt
H COOMe+
1 mol% Ph3PAuCl
5 mol% BF3, Et2O
50 ºC, CH3NO2
78 % Yield
COOMe
(Z:E) = 100
(Z:E) = 3.97
(1)
(2)
(3)
Scheme 5
R2
N
H
R1
O
R3
5-25 mol% NaAuCl4
25-60 ºC, EtOH
N
H
R1
R2
R3
O
64-92 % Yield
R2
N
H
O
R3
5-25 mol% NaAuCl4
25-60 ºC, EtOH
N
H
R1
58-94 % Yield
R1
R2
R3
O
Scheme 6
Biopharmaceutical applications of nanogold 1854.1.2. Gold-catalyzed aliphatic carbon–oxygen bond formations
Methane was oxidized into methanol using the combination of
metallic gold as a catalyst and selenic acid (H2SeO4) as an oxi-
dant in 96% of sulfuric acid (H2SO4) as a solvent at 180 C
(Jones et al., 2004). Cyclohexane was oxidized at 150 C using
gold supported on ZSM-5 (Au/ZSM-5) as a catalyst with
1 MPa of oxygen as a source of oxidant (Scheme 11) Zhao
et al., 2004. Cyclohexene was oxidized, catalyzed by NaAuCl4
using O2 as an oxidant, into cyclohexen-3-ol as the main prod-
uct together with smaller amounts of cyclohexene-3-one and
the epoxide (Shul’pin et al., 2001).
4.1.3. Alcohols selective oxidation
The gold-based catalysts have demonstrated very interesting
and promising activity, and different types of gold-based
homogeneous and heterogeneous catalysts in the form of metal
complex or nanoparticles have been developed for the oxida-tion of alcohols into corresponding aldehydes or ketones
(Hu et al., 2007).
4.1.4. Gold-catalyzed C–N formation
Scheme 12 shows the use of arylgold(III) to C–N bond forma-
tions via the activation of aromatic or benzylic C–H bonds
using 2 mol% of AuCl3 in CH2Cl2 at room temperature (Li
et al., 2007; Kharasch and Isbell, 1931; de Graaf et al., 1976).
4.2. Biomedical applications
4.2.1. Biosensing and diagnostic
4.2.1.1. Immunohistochemistry. Gold nanoparticles are useful
in the construction of electrochemical immunosensors where
it plays a crucial role both in the enhancement of the electro-
chemical signal transducing the binding reaction of antigens
at antibody immobilized surfaces and in the ability of
N
H
R1
R2
R3
O
AuCl2
N
H
R1
R2
R3
O
H
N
H
R1
[AuCl2]+
H+
H+
N
H
R1
AuCl2
R2
R3
O
A
B
Scheme 7
OMe
MeO OMe
NTs
Ar
+
5 mol% AuCl3
15 mol% Ag|OTf
OMe
MeO OMe
Ar
NHTs
76-84 % Yield
25 C CH2Cl2
NTs
Ar
+
5 mol% AuCl3
15 mol% Ag|OTf Ar
NHTs
34-85 % Yield
80 C CH2Cl2
(1)
(2)
Scheme 8
186 F.K. Alanazi et al.increasing the amount of immobilized immunoreagents in a
stable mode. Hepatitis B virus surface antigen was detected
using electrochemical impedance spectroscopy (EIS) through
immobilization of the antibody onto gold nanoparticles-mod-
iﬁed 4-aminothiophenol self-assembled monolayers (Wang
et al., 2004). Potentiometric and amperometric immunosensors
for Hepatitis B virus surface antigen detection were also con-
structed by electrostatic adsorption of the antibody onto gold
nanoparticles/tris(2,2-bipyridyl)cobalt (III) multilayer ﬁlms
(Tang et al., 2005) or by immobilization of the antibody onto
gold nanoparticles-modiﬁed thiol-containing sol–gel network
(Tang et al., 2006). The antigen–antibody reaction is detectedthrough measuring the changes in the electric potential before
and after. Furthermore, a different strategy was used to fabri-
cate an amperometric immunosensor based on immobilization
of hepatitis B antibody on a gold electrode modiﬁed with gold
nanoparticles and horseradish peroxidase (Zhuo et al., 2005) in
order to avoid non-speciﬁc adsorption and also amplify the re-
sponse of the antigen–antibody reaction. Also, a gold nano-
particles-based potentiometric immunosensor was developed
for detecting diphtheria antigen and diphtherotoxin (Dianping
et al., 2005). An electrode fabricated from gold nanoparticles
was used for the determination of aﬂatoxin B1 based on
immunoreactions (Liu et al., 2006). Amperometric immuno-
O
O
R2
R1
2.5 mol% AuCl3
7.5 mol% AgOTf
25-83C  ClCH2CH2Cl
R1
O
OH
R2
OMe
MeO OMe
+
5 mol% AuCl3
15 mol% AgOTf
25-83C  ClCH2CH2Cl
O
OMe
MeO OMe
OH
58-85% Yield
52% Yield
(1)
(2)
Scheme 9
O
R
OMeO
5 mol% AuCl3
15 mol% AgOTf
120 C  ClCH2CH2Cl
O
O
45-97% Yield
Scheme 10
H
O
OH
1% Au/graphite
3 bar O2
70 C Solvent
MeOH  65% Yield
H2O  100% Yield
Scheme 11
Biopharmaceutical applications of nanogold 187sensor made of modiﬁed nanogold monolayer was used for
Schistosoma japonicum (Sj) antigen Lei et al., 2003; Xia
et al., 2005.
4.2.1.2. Detection of disease biomarker. Gold nanoparticles
have been used in the assembly of electrochemical and amper-
ometric biosensors for the diagnosis of patients with germ cell
tumors and hepatocellular carcinoma. This is done by the
detection of a tumor marker, alpha-fetoprotein (AFP), an
oncofetal glycoprotein (Ying et al., 2005). Carbohydrate anti-
gen 19-9 (CA19-9) is one of the most important carbohydrate
tumor markers expressed in many malignancies as pancreatic,
colorectal, gastric and hepatic carcinomas (Reetz et al., 2003).
Another carbohydrate antigen CA125 is also an important
marker determined by nanogold immunosensors (Xiao-Hong,
2007). Carcinoembryonic antigen (CEA) is a well-known mar-ker associated with the progression of colorectal tumors. PSA
is prostate-speciﬁc antigen in prostate cancer (Liu, 2008). Elec-
trochemical detection of these disease markers was accom-
plished by the amperometric changes occurring before and
after the antigen–antibody interaction Xiao-Hong, 2007).
4.2.1.3. DNA-modiﬁed nanogold electrochemical biosensors.
Gold nanoparticles-modiﬁed electrodes are used in the assem-
bly of electrochemical DNA biosensors. They constitute useful
analytical tools for sequence-speciﬁc DNA diagnosis and
detection due to their inherent advantages of low cost, sensitiv-
ity and rapidity of response (Odenthal and Gooding, 2007).
Pathogens, bacteria and viruses, can be detected via their un-
ique, respective nucleic acid sequences. An exemplary target
mixture containing Escherichia coli and Stachybotrys
chartarum, an airborne pathogen, was then introduced. These
DNA biosensors use the unique binding event between E. coli
single-stranded DNA-binding protein (SSB) and single-
stranded oligonucleotides conjugated to gold (Au) nanoparti-
cles. The ampliﬁed oxidation signal of Au nanoparticles pro-
vided a detection limit of 2.17 pM target DNA (Kerman
et al., 2004).
An important associated aspect is the accurate, sensitive,
and rapid detection of the transgenic plants. DNA electro-
chemical sensors are most likely to become an analytical tool
for the transgenic plant products. Nanogold-modiﬁed
electrodes represent DNA electrochemical biosensor and are
described as accurate, rapid and sensitive for the electrochem-
ical impedance spectroscopy detection of the sequence-speciﬁc
DNA related to transgene in the transgenic plants. These
DNA-modiﬁed gold electrodes are useful electrochemical
genosensors for gene analysis, detection of genetic disorders,
tissue matching, and forensic applications due to their high
sensitivity, small dimensions, low cost and compatibility.
4.2.2. Therapeutic application of gold nanoparticles
Gold nanoparticles exploit their unique chemical and physical
properties for transporting and unloading the pharmaceuticals.
First, the gold core is essentially inert and is their ease of synthe-
sis; monodisperse nanoparticles can be formed with core sizes
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188 F.K. Alanazi et al.ranging from 1 to 150 nm (Connor et al., 2005). Second advan-
tage is imparted by their ready functionalization, generally
through thiol linkages. In addition, their photophysical proper-ties could trigger drug release at remote place (Skirtach et al.,
2006). Fig. 6 shows various drug, gene, and protein delivery
using GNPs.
Biopharmaceutical applications of nanogold 1894.2.2.1. Gold nanoparticles in drug delivery. Drug delivery sys-
tems (DDSs) provide positive attributes to a ‘free’ drug by
improving solubility, in vivo stability, and biodistribution.
They can also alter unfavorable pharmacokinetics of some
‘free’ drugs. Moreover, huge loading of pharmaceuticals on
DDSs can render ‘drug reservoirs’ for controlled and sustained
release to maintain the drug.
Hong et al. (2006) have demonstrated cellular delivery and
glutathione-mediated, GSH-mediated release of a hydrophobic
dye (BODIPY), as a model of hydrophobic drugs, using func-
tionalized gold nanoparticles (fGNPs). The particles (core
d= 2 nm) featured a mixed monolayer composed of
tetra(ethyleneglycol)ylated cationic ligands (TTMA) and ﬂuo-
rogenic ligands (HSBDP). The cationic nature facilitates the
crossing of cell-membrane barrier, and the ﬂuorophore probes
possible drug release mechanism. Controlled release of the dye
was veriﬁed by treating mouse embryonic ﬁbroblast cells with
varying concentration of glutathione monoester. A recent
study has reported on the therapeutic ability of a novel cyclo-
dextrin-covered gold nanoparticle (AuNP) carrier for nonco-
valent encapsulation of an anti-cancer drug (Xiaohua et al.,
2006). The surface of the AuNPs was functionalized with
cyclodextrin as a drug pocket, anti-epidermal growth factor
receptor (anti-EGFR) antibody as a targeting moiety, and
poly(ethyleneglycol) (PEG) as an anti-fouling shell. b-Lapach-
one, an anti-cancer drug, was efﬁciently encapsulated into the
hydrophobic cavity of cyclodextrin on the surface of the AuNP
carriers (AuNP-1). The glutathione-mediated release of b-
lapachone from the surface of AuNP-1 was demonstrated by
an experiment with MCF-7 (low glutathione concentration)
and A549 cells (high glutathione concentration) (Xiaohua
et al., 2006).
GNPs could possibly be employed in the delivery of dia-
tomic therapeutic agents, like singlet oxygen, or nitric oxide.
Singlet oxygen (1O2), a cytotoxic species, is involved in the
photodynamic therapy of cancer (Xiaohua et al., 2008). Rus-
sell and coworkers decorated the surface of GNPs with phthal-
ocyanines (PCs), a photosensitizer to generate singlet oxygen
with good quantum yield (Hone et al., 2002). Nitric oxide
(NO) regulates multiple cellular processes including angiogen-
esis, vasodilatation, and the immune response (Mocellin et al.,
2007). Controlled release of NO could be an effective therapy
for hypoxic respiratory failure associated with pulmonary
hypertension. Schoenﬁsch et al. demonstrated that NO can
be efﬁciently stored by covalent linking with polyamine-stabi-
lized GNP via formation of acid-labile N-diazeniumdiolate
(Polizzi et al., 2007). They were able to show effective release
of NO from the water-soluble nanocontainers in acidic condi-
tion (pH = 3). pH responsive materials are applicable for drug
delivery due to the presence of mild acidic environment inside
inﬂammatory and tumor tissues (pH  6.8), or cellular vesicles
such as endosomes (pH  5.5–6) and lysosomes (pH  4.5–
5.0) Engin et al., 1995; Yang et al., 2005.
4.2.2.2. Gold nanoparticles in biomolecules delivery. In addition
to the delivery of small molecules, tunable size and functional-
ity of gold nanoparticles make them a useful scaffold for efﬁ-
cient recognition and delivery of biomolecules such as
peptides, proteins, or nucleic acids like DNA or RNA.
Efﬁcient and safe nonviral gene delivery systems are a pre-
requisite for the clinical application of therapeutic genes. In
some studies, it was reported that an enhancement of the trans-fection efﬁciency of plasmid DNA happened via the use of
positively charged colloidal gold nanoparticles (GNPs). The
results of this study suggested that the GNP/DNA complexes
may harbor the potential for development into efﬁcient and
safe gene delivery vehicles (Noh et al., 2007). Gold nanoparti-
cles chemically modiﬁed with primary amine groups were
developed as intracellular delivery vehicles for therapeutic
small interfering RNA (siRNA).
The electrostatic binding of siRNA and gold nanorods has
been recently reported by the Prasad group (Bonoiu et al.,
2009). They conjugated cetyltrimethylammonium bromide
(CTAB) gold nanorods to siRNA (against DARPP-32 gene
in dopaminergic neuronal (DAN) cells) and studied the uptake
of conjugates inside the DAN cells. They found that the siR-
NA was efﬁciently delivered into DAN cells after treatment
with the gold nanorod–siRNA conjugates and cell viability
was 98%. Moreover, there was still about 67% knockdown
of DARPP-32 gene expression after 120 h for the cells that
were incubated with the gold nanorod–siRNA conjugates,
compared to only about 30% knockdown for cells treated with
a commercial transfection agent as a control. This study also
conﬁrms that gold nanoparticles can be used as an innovative
vehicle to deliver genes into neuron cells. According to the
authors of that study, this might one day provide the basis
for a nanotherapy to treat drug addiction in patients (Bonoiu
et al., 2009).
Recent work has shown that the combination of photother-
apy with conventional gene therapy offers a high possibility to
improve the efﬁciency of gene delivery into cells (Mariko et al.,
2005). For example, Niidome et al., (2006) have investigated
the release of plasmid DNA from spherical gold nanoparticles
after exposure to pulsed laser irradiation.
Interference of gene expression can also be performed
using gold nanorods. Lee et al. have demonstrated the idea
of a remote optical switch for localized and selective control
of gene interference. Thiol-modiﬁed sense oligonucleotides
were conjugated with gold nanorods. Thereafter, the antisense
oligonucleotides were hybridized to the sense oligonucleo-
tides. After laser irradiation, the double strands of the oligo-
nucleotides were denatured and the antisense oligonucleotides
were released from the complex structure. These antisense oli-
gonucleotides can bind to the corresponding mRNA while the
sense oligonucleotides were still attached to gold nanorods
through thiol bonds. Once the mRNA/oligodeoxynucleotide
heteroduplex is formed, its structure will be recognized and
degraded by RNaseH enzymes inside the cell, thereby inhibit-
ing the normal genetic function of the mRNA (Lee et al.,
2009).
Electroporation is another external stimulus that can be
used to release genes from a gold nanoparticle. Kawano
et al. (2006) have investigated gene delivery in vivo using gold
nanoparticles excited with electrical pulses. In this study, gold
nanoparticles were modiﬁed with mPEG-SH5000 and conju-
gated with plasmid DNA. These were then injected into anes-
thetized mice. After a suitable delay to allow the conjugates to
spread in the mouse, electrical pulses were then applied to the
left lobe of its liver. The result was that gene expression was
detected in the major mouse organs. In contrast, the injection
of naked DNA resulted in a 10-fold lower level of detection.
The degradation of DNA in blood, which occurs in times as
short as 5 min, is evidently the reason for the inefﬁcient trans-
fection in the latter case. This study illustrates yet another
190 F.K. Alanazi et al.interesting approach to improve gene delivery using gold
nanoparticles.
4.2.2.3. Gold nanoparticles for protein delivery. Gold nanopar-
ticles can be novel nanocarriers of peptides and proteins of
interest. Cationic tetraalkylammonium-functionalized GNPs
recognize the surface of an anionic protein through comple-
mentary electrostatic interaction and inhibit its activity (Verma
et al., 2004). The activity was recovered due to the release of
free protein by treating the protein–particle complex with glu-
tathione, showing GNPs as potential protein transporters.
Pokharkar and coworkers have demonstrated functionalized
gold nanoparticles as the carriers of insulin (Bhumkar and
Joshi, 2007). Chitosan-coated particles strongly adsorb insulin
on their surface, and are effective for transmucosal delivery of
insulin.
4.2.2.4. Gold nanoparticles for site-directed photothermal appli-
cations. Gold nanoparticles cause local heating when they are
irradiated with light (800–1200 nm). El-Sayed et al. have
recently reported about the potential use of GNPs in photo-
thermal destruction of tumors (Huang et al., 2007). Citrate-sta-
bilized GNPs (core d= 30 nm) were coated with
anti-EGFR (epidermal growth factor receptor) to target
HSC3 cancer cells (human oral squamous cell carcinoma).
The use of GNPs enhanced the efﬁcacy of photothermal ther-
apy by 20 times. In another approach, optically responsive
delivery systems have been designed by incorporation of gold
nanospheres into the shells of capsules. Caruso et al. prepared
microcapsules via layer-by-layer (LBL) technique to encapsu-
late macromolecules like ﬂuorescein-labeled dextrans (Angela-
tos et al., 2005). The capsule-shells were doped with GNPs,
which respond against near infrared (NIR) light. FITC-dextran
was released upon laser (1064 nm) treatment due to the rupture
of the shell. Skirtach and coworkers have extended this strategy
to deliver encapsulated materials from polyelectrolyte-multi-
layer capsules inside living cancer cells (Skirtach et al., 2006).
4.2.2.5. Gold nanocarriers applied in vivo. Patra et al. (2008)
have developed a nanoparticle-based targeted drug delivery
system (DDS), which contains cetuximab (C225) anti-epider-
mal growth factor receptor (EGFR) antibody as the targeting
agent, gemcitabine as the anti-cancer drug, and gold nanopar-
ticles as the delivery vehicle. The administration of this tar-
geted delivery system resulted in the signiﬁcant inhibition of
pancreatic tumor cell proliferation in vitro and orthotropic
pancreatic tumor growth in vivo. In the near future, this strat-
egy could be used as a generalized approach for the treatment
of a variety of cancers including pancreatic cancer.
Wu and coworkers have demonstrated that MTX–GNP
conjugate inhibits tumor growth in a mouse ascites model of
Lewis lung carcinoma (LL2) Chen et al., 2007. Paciotti et al.
carried out an in vivo study to investigate the therapeutic effect
of PEGylated gold colloids (cAu-PEG-TNF) with adsorbed
protein (tumor necrosis factor, TNF) (Paciotti et al., 2004).
When cAu-PEG-TNF was injected intravenously into mice,
they largely accumulated in MC-38 colon carcinoma tumors
compared to liver, spleen, or other healthy organs. TNF pro-
vided both targeting and therapeutic action via killing the tar-
geted cells. Importantly, the particles were more effective in
diminishing tumor mass than ‘free’ TNF. Recent studies by
this group have demonstrated enhanced tumor therapy bygrafting paclitaxel, an anti-cancer drug, onto cAu-PEG-TNF
(Paciotti et al., 2006).
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